Karius
3 employees
Artificial Intelligence (AI)
Series C · $315.0M
Open positions (8)
Company details
Team Size3
IndustryArtificial Intelligence (AI)
Funding
Total raised
$315.0M
Last stage
Series C
Investors
Gilde Healthcare
Total raised
$315.0M
Last stage
Series C
Investors
Mickey Kertesz
Co-founded Karius in 2014, building on pathogen detection technology developed at Stanford. Previously CEO and co-founder of Moleculo (acquired by Illumina). PhD in computational biology from Weizmann Institute of Science; postdoctoral work in bioengineering at Stanford.
LinkedInTim Blauwkamp
Co-founder and CSO of Karius. Previously Staff Scientist at Illumina and Head of Molecular Biology at Moleculo. Background in chemistry and biochemistry from Grand Valley State University.
Stephen Quake
Co-founder of Karius. Renowned Stanford professor in bioengineering whose lab developed the foundational microbial cell-free DNA technology underlying the Karius Test.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.